Medicare spending on HMOs and stand-alone drug plans: what is it worth to beneficiaries?

Abstract

(1) Medicare beneficiaries value the expansion of stand-alone prescription drug plans more than they value the expansion of HMOs. (2) The addition of subsidized stand-alone prescription drug plans generates nine times as much value per government dollar as the increase in payments to HMOs.